Two is Better Than One: A Novel Venous Access System for Intermittent Apheresis

Apheresis Clinical Trial

Official title:
Two is Better Than One: A Novel Venous Access System for Intermittent Apheresis

Status Completed

Clinical Trial Summary

Purpose: To describe a novel configuration of venous access for the performance of intermittent apheresis. Participants: 20 participants at UNC who were referred for change from a vortex port to a powerflow port. Procedures (methods): Placement of one of two configurations of the powerflow port and follow up visits between January 1, 2019 and December 31, 2023.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Apheresis

Clinical Trial Details

NCT number	NCT04846374
Study type	Observational
Source	University of North Carolina, Chapel Hill
Contact
Status	Completed
Phase
Start date	May 26, 2021
Completion date	April 14, 2023

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT00562601` - LCI Apheresis to Obtain Plasma or White Blood Cells
Completed	`NCT00042627` - Prevalence and Risk of Cataracts in Granulocyte Donors	N/A
Completed	`NCT05191290` - Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation	Phase 4
Recruiting	`NCT00001846` - Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Recruiting	`NCT04939805` - CRP Apheresis in STEMI	N/A